b Tested in sodium chloride 0.9%.
c Refer to Appendix for the composition of parenteral nutrition solutions. TNA indicates a 3-in-1 admixture, and TPN indicates a 2-in-1 admixture.
d Tested in sterile water for injection.
e Tested in Ringer’s injection, lactated.
f Injected via Y-site into an administration set running azithromycin.
g Test performed using the formulation WITHOUT edetate disodium.
h Test performed using the formulation WITH edetate disodium.
i Piperacillin component. Piperacillin in an 8:1 fixed-ratio concentration with tazobactam.
j Trimethoprim component. Trimethoprim in a 1:5 fixed-ratio concentration with sulfamethoxazole.
k Tested as the premixed infusion solution.
l If sterile water for injection is used as the diluent, manufacturers recommend a maximum volume per dose of 50 mL.
m Presence or absence of edetate disodium not specified.
n Quinupristin and dalfopristin components combined.
p Tested in both dextrose 5% and sodium chloride 0.9%.
q Ceftolozane component. Ceftolozane in a 2:1 fixed-ratio concentration with tazobactam.
r Meropenem component. Meropenem in a 1:1 fixed-ratio concentration with vaborbactam.
s Not specified whether concentration refers to single component or combined components.
t Sulbactam component. Sulbactam in a 1:1 fixed-ratio concentration with durlobactam.